VB Spine A.I CyberSecurity Scoring
11/03/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for VB Spine in 2026.
No incidents recorded for VB Spine in 2026.
No incidents recorded for VB Spine in 2026.
Medical Equipment Manufacturing
As a leading medical technology company, B. Braun protects and improves the health of people around the world. For more than 185 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits. More than 64,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops integrated solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2024, the B. Braun Group generated sales of € 9.1 billion. Imprint: https://www.bbraun.com/en/imprint.html Privacy Policy: https://www.bbraun.com/en/privacy-policy.html
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com. See community guidelines here: bit.ly/4vTpKjz
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Latest updates, reports, and threat intel affecting the global network.
VB Spine has signed a definitive agreement to acquire Augmedics' xvision Spine System to add augmented reality (AR) navigation to its...
NEW YORK & CHICAGO, February 16, 2026--VB Spine signs agreement to acquire xvision Spine System®, expanding its visualization portfolio,...
VB Spine LLC announced Thursday that it has agreed to acquire the SpineHawk platform from Robotron Surgical Technologies,...
VB Spine has agreed to acquire the SpineHawk intraoperative spinal visualisation platform from Robotron Surgical Technologies.
VB Spine LLC today announced an agreement to acquire the SpineHawk platform from Robotron Surgical Technologies, expanding VB Spine's...
NEW YORK, January 06, 2026--VB Spine completes the acquisition of Stryker's Cestas, France spinal implant manufacturing facility.
NEW YORK & SYDNEY, July 31, 2025--VB Spine LLC ("VB Spine"), a global, family-led spine company dedicated to advancing patient outcomes,...
A flaw has been found in OpenClaw up to 2026.9.5. Affected is the function createCanvasHostHandler of the file extensions/canvas/src/host/server.ts of the component Canvas Host Route. Executing a manipulation can lead to denial of service. The attack can be launched remotely. The exploit has been published and may be used. Fix suggestion's "streaming/size-limit" was never shipped - latest 2026.9.5 still buffers the whole file via readFile() (src/canvas/serve.runtime.ts:17,114), unlike the sibling WS path which caps at 64KB. The vendor was contacted early about this disclosure.
A security vulnerability has been detected in DLR-RM stable-baselines3 up to 2.9.0. This affects the function PPO.load/load_replay_buffer/VecNormalize.load of the file save_util.py. Such manipulation leads to deserialization. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used. In v2.9.0 the PyTorch tensor load path is hardened (weights_only=True), but that hardening was later reverted on master via PR #1913 "Hotfix: revert loading with weights_only=True" [blocked] to fix PyTorch 1.13 compat - so even the one "safe" path is inconsistent across versions. #2281 was closed as a duplicate of #1831 since both are unsafe pickle deserialization - but #1831's fix (PR #41) only gated the Hugging Face Hub loader in the separate huggingface_sb3 package. This finding covers the core stable_baselines3 load APIs (PPO.load, load_replay_buffer, VecNormalize.load), which have no safe mode or gate and remained exploitable in v2.9.0 until the outstanding hardening (PR #2264) ships.
A vulnerability was detected in dmlc dgl up to 2.1.0. This impacts the function load_info/_read_torch_data of the file utils.py. Performing a manipulation of the argument path results in deserialization. The attack can be initiated remotely. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.
A weakness has been identified in piskvorky gensim up to 4.4.0. The impacted element is the function Load of the file gensim/utils.py of the component Model Loader. This manipulation of the argument fname causes deserialization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. Maintainer closed #3663 same-day with no comment, PR, or fix; repo's last push (2025-11-01) predates the report, so the unsafe pickle.load in SaveLoad.load remains unguarded at develop HEAD.
A security flaw has been discovered in JusticeRage Manalyze 1.0.0. The affected element is the function PE::_parse_debug of the file manape/pe.cpp of the component PE Parser. The manipulation of the argument misc.Length results in integer underflow. The attack may be performed from remote. The patch is identified as 3e299685759f4f767088871de58c5d07f98ee382. A patch should be applied to remediate this issue.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.